Stock Code
603707.SH
| FDF | ||||
| Name | Vial/pfs | Strength | Approval Status | Approved by |
| Heparin Sodium Injection | Vial | 5000 IU/mL 25000IU/5mL 1000 IU/mL 10000 IU/mL 20000 IU/mL 2000 IU/2mL 40000 IU/4mL 50000 IU/10mL 10000 IU/10mL 30000 IU/30mL | Approved | US FDA |
| Heparin Sodium Injection | PFS | 5000 IU/0.5mL ，5000 IU/mL | Approved | US FDA |
| Enoxaparin Sodium Injection | PFS | 80mg/0.8mL ，100mg/mL ， 120mg/0.8mL ，150mg/mL | Approved | US FDA/EU EMA/China NMPA |
| Dalteparin Sodium Injection | PFS | 0.2ml:5000IU，0.3ml:7500IU | Approved | China NMPA |
| Nadroparin Calcium Injection | PFS | 0.3ml:3075IU，0.4ml 4100IU， 0.6ml:6150IU | Approved | China NM PApprovedA |
| Atracurium Injection | Vial | 50mg/5mL ， 100mg/10mL | Approved | US FDA |
| Cisatracurium Injection | Vial | 10mg/5mL ， 20mg/10mL， 100mg/20mL | Approved | US FDA/China NMPA |
| Fulvestrant Injection | PFS | 250mg/5mL | Approved | US FDA |
| Doxercalciferol Injection | Vial | 4μg/2mL | Approved | US FDA |
| Milrinone Lactate Injection | Vial | 10mg/10mL ，20mg/20mL ， 50mg/50mL | Approved | US FDA/China NMPA |
| Fondaparinux Sodium Injection | PFS | 2.5mg/0.5mL | Approved | China NMPA |
| Phenylephrine Injection | Vial | 10mg/mL ， 50mL/5mL ， 100mg/10mL | Approved | US FDA |
| Gemcitabine for Injection | Vial | 200mg/vial ， 1g/vial | Approved | US FDA |
| Levoleucovorin Injection | Vial | 175 mg/17.5 mL ， 250 mg/25 mL | Approved | US FDA |
| Levoleucovorin for Injection | Vial, lyo | 50mg/vial | Approved | US FDA |
| Carboplatin injection | Vial | 50 mg/5 mL ， 150 mg/15 mL 450 mg/45 mL ， 600 mg/60 mL | Approved | US FDA |
| Cytarabine Injection | Vial | 1 g/50 mL ， 2 g/20 mL ， 100 mg/5 mL | Approved | US FDA |
| Bleomycin for Injection | Vial, lyo | 15 u/vial ， 30 u/vial | Approved | US FDA |
| Topotecan Hydrochloride for lnjection | Vial, lyo | 4 mg/vial | Approved | US FDA |
| Bendamustine HCl for Injection | Vial, lyo | 25mg/vial ， 100mg/vial | Approved | US FDA/China NMPA |
| Bortezomib for Injection | Vial, lyo | 3.5mg/vial | Approved | US FDA |
| Clofarabine Injection | Vial | 20mg/20mL | Approved | US FDA |
| Busulfan Injection | Vial | 60mg/10mL | Approved | US FDA/China NMPA |
| Dactinomycin for Injection | Vial, lyo | 0.5mg/vial | Approved | US FDA |
| Azacitidine for Injection | Vial, lyo | 100 mg/vial | Approved | China NMPA |
| Mycophenolate Mofetil for Injection | Vial, lyo | 500 mg/vial | Approved | US FDA |
| Tigecycline for Injection | Vial, lyo | 50 mg/vial | Approved | US FDA/China NMPA |
| Glycopyrrolate Injection | Vial | 0.2 mg/mL, 0.4 mg/2 mL, 1 mg/5 mL, 4 mg/20 mL | Approved | US FDA |
| Melphalan for Injection | Vial, lyo | 50mg/vial | Approved | US FDA |
| Daptomycin for Injection | Vial, lyo | 350mg/vial, 500mg/vial | Approved | US FDA |
| Decitabine for Injection | Vial, lyo | 50 mg/vial | Approved | US FDA |
| Haloperidol Decanoate Injection | Vial | 50 mg/mL, 100 mg/mL, 500 mg/5 mL | Approved | US FDA |
| Carmustine for Injection | Vial, lyo | 100mg/vial | Approved | US FDA |
| Bivalirudin for Injection | Vial, lyo | 250mg/vial | Approved | US FDA |
| Dexmedetomidine Injection | Vial | 200mcg/2mL | Approved | US FDA |
| Neostigmine Methylsulfate Injection | Vial | 5mg/10mL, 10mg/10mL | Approved | US FDA |
| Isosulfan Blue Injection | Vial | 50mg/5mL | Approved | US FDA |
| Succinylcholine Chloride Injection | Vial | 200mg/10mL ，100mg/2mL | Approved | US FDA |
| Furosemide Injection | Vial | 20mg/2mL, 40mg/4mL, 100mg/10mL | Approved | US FDA |
| Regadenoson Injection | PFS | 0.4mg/5mL | Approved | US FDA |
| Voriconazole for Injection | Vial, lyo | 200mg/vial | Approved | US FDA |
| Ganirelix Acetate Injection | PFS | 0.25mg/0.5mL | Approved | US FDA |
| Eptifibatide Injection | Vial | 20mg/10mL, 75mg/100mL | Approved | US FDA/China NMPA |
| Enoxaparin Sodium Injection | Vial | 300mg/3mL | Approved | US FDA |
| Mitomycin for Injection | Vial, lyo | 5 mg/vial, 20 mg/vial, 40 mg/vial | Approved | US FDA |
| Vancomycin for Injection | Vial, lyo | 500mg/vial, 750mg/vial, 1g/vial, 5g/vial, 10g/vial | Approved | US FDA |
| Micafungin Sodium for Injection | Vial, lyo | 50mg/vial, 100mg/vial | 2022 Q4 | US FDA |
| Docetaxel Injection | Vial | 20mg/2mL, 80mg/8mg, 160mg/16mL | 2022 Q4 | US FDA |
| Nelarabine Injection | Vial | 250mg/50mL | 2022 Q4 | US FDA |
| Pemetrexed for Injection | Vial, lyo | 100mg/vial, 500mg/vial | 2022 Q4 | US FDA |
| Rocuronium Bromide Injection | Vial | 50mg/5mL, 100mg/10mL | 2022 Q4 | US FDA |
| Zoledronic Acid Injection | Vial | 5mg/100mL | 2022 Q4 | US FDA |
| Thiamine Injection | Vial | 200mg/2mL | 2022 Q4 | US FDA |
| Fluorouracil Injection | Vial | 500 mg/10 mL, 1 g/20 mL | 2022 Q4 | US FDA |
| Perixafor Injection | Vial | 24mg/1.2mL | 2022 Q4 | US FDA |
| Thiotepa for Injection | Vial, lyo | 15mg/vial, 100mg/vial | 2022 Q4 | US FDA |
| Pantoprazole Sodium for Injection | Vial, lyo | 40mg/vial | 2022 Q4 | US FDA |
| Glatiramer Acetate Injection | PFS | 20mg/mL, 40mg/mL | 2022 Q4 | US FDA |
| Bupivacaine Hydrochloride Injection | Vial | 75mg/10mL, 225mg/30mL, 125mg/50mL, 250mg/50mL | 2022 Q4 | US FDA |
| Palonosetron Hydrochloride Injection | Vial | 0.25 mg/5 mL | 2023 Q1 | US FDA |
| Leucovorin Calcium for Injection | Vial, lyo | 50mg/vial, 100mg/vial, 200mg/vial, 350mg/vial | 2023 Q1 | US FDA |
Product List.pdf